Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction

BACKGROUND: Cardiovascular diseases (CVDs) are the leading causes of mortality worldwide. Currently, the best treatment options for myocardial infarction focus on the restoration of blood flow as soon as possible, which include reperfusion therapy, percutaneous coronary intervention, and therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shouwen, Li, Jingfang, Hu, Shunpeng, Wu, Fangfang, Zhang, Xianzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045899/
https://www.ncbi.nlm.nih.gov/pubmed/30022826
http://dx.doi.org/10.2147/IJN.S165590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045899/
https://www.ncbi.nlm.nih.gov/pubmed/30022826
http://dx.doi.org/10.2147/IJN.S165590

Ejemplares similares